Mortality rates from coronary heart disease are lower in Swedish men and among Finnish migrants who have lived in Sweden for over 20 years than in men living in Finland. Sero-epidemiological studies, investigations of atheromatous plaque specimens, in vitro animal models and anti-chlamydial antibiotic trials have given support to the hypothesis that Chlamydia pneumoniae (Cpn) has a role in atherosclerosis. We investigated whether men with a similar genetic background but living permanently in Finland or Sweden have differences in the prevalence of Cpn seropositivity, and whether chronic Cpn infection is associated with markers of subclinical atherosclerosis. We measured anti-Cpn antibodies and ultrasonographic markers of subclinical atherosclerosis, including carotid intima-media thickness, carotid artery compliance and brachial artery flowmediated dilatation, in a population of 76 migrant-discordant male twin pairs (152 men). The number of men with seropositivity to Cpn infection (defined as IgA 1:64 and IgG 1:128) was greater in Finland than in Sweden (21.5 % compared with 10.5 %; P = 0.046). Cpn seropositivity accompanied by elevated C-reactive protein (CRP) levels (> 1 mg/l) was associated with attenuated brachial artery flow-mediated dilatation (3.3 + − 0.3 %, compared with 5.5 + − 0.4 % in men with no signs of Cpn infection; P < 0.001).Thus, among Finnish twin brothers discordant for migration to Sweden, the prevalence of Cpn seropositivity is higher for those living in Finland, and men with Cpn seropositivity combined with elevated CRP levels had attenuated endothelial function. These findings offer insight into the mechanism whereby chronic Cpn infection may increase the risk of coronary heart disease.
INTRODUCTION
Inflammatory reactions against irritants, such as modified low-density lipoprotein (LDL), cytomegalovirus or Chlamydia pneumoniae (Cpn), in the arterial wall have been suggested to trigger atherogenesis and plaque formation [1] [2] [3] . In 1998, Saikku and co-workers [4] found that nearly 70 % of patients with acute myocardial infarction showed pronounced IgM, IgA and IgG antibody responses to chlamydial lipopolysaccharide between two serum samples taken 4 weeks apart. In addition, 68 % of patients with acute myocardial infarction and 50 % of patients with chronic coronary heart disease (CHD) had raised levels of IgG and/or IgA antibodies to Cpn [4] . Further support for a role for Cpn in atherogenesis came from a later study where circulating immune complexes containing chlamydial lipopolysaccharide were found in patients with acute myocardial infarction [5] . Raised IgA titres against Cpn and the presence of immune complexes containing Cpn lipopolysaccharide antigen were associated with an increased risk of cardiovascular events in the Helsinki Heart Study [6] . A role for Cpn in the atherosclerotic process was strengthened when Cpn-specific circulating immune complexes were found to be present in 41 % of patients with chronic CHD [7] . Furthermore, the geometric mean antibody titre for Cpn IgG was higher in patients with angiographically detectable coronary artery disease. The estimated risk for CHD was greater among subjects with high ( 1:64) IgG titres than among subjects with low antibody titres [8] .
In contrast, in a large follow-up study of healthy men, no association between Cpn IgG seropositivity (IgG titres from 1:16 to 1:256) and CHD was found [9] . Moreover, Danesh and co-workers did not find any association between CHD and Cpn IgA or IgG titres [10, 11] .
Increased intima-media thickness (IMT) of the carotid artery is a structural marker of subclinical atherosclerosis [12] . IMT is associated with traditional vascular risk factors [13] and the severity and extent of coronary artery disease [14] . A measurable difference in carotid IMT between Cpn seropositive and seronegative subjects was found in the ARIC study [15] . In another study by Markus and co-workers [16] in a German population of 983 men and women, no evidence was found for a relationship between Cpn infection and carotid artery IMT, although there was a significant association between IgA seropositivity and severe (> 50 %) mean carotid stenosis [16] . Similar results were found in another study, in which high serum anti-chlamydial IgA levels (IgA 1:128) were significantly associated with the occurrence of symptomatic carotid artery disease [17] . Recently, enhanced progression of early carotid atherosclerosis was observed in patients with cerebrovascular disease who had elevated titres of anti-Cpn antibodies [18] . Patients with increased levels of C-reactive protein (CRP) and Cpn seropositivity showed the most pronounced IMT progression [18] .
Brachial artery flow-mediated dilatation (FMD) is a widely used method for the assessment of endothelial function non-invasively in humans [19] . Traditional risk factors, such as smoking, hypercholesterolaemia and diabetes, are associated with impaired endothelial function in subjects without overt CHD, suggesting that endothelial dysfunction is an early marker of atherosclerosis [19] . Endothelial dysfunction has been observed in apolipoprotein E-knockout mice exposed to Cpn [20] . Sharma and co-workers [21] found a trend towards reduced FMD in subjects with anti-Cpn IgA or elevated CRP levels. There are also reports showing attenuated FMD responses with increased levels of CRP in healthy subjects [22] and patients with coronary artery disease [23] . These observations thus suggest that lowgrade inflammation may impair endothelial integrity. No studies to date, however, have examined the combined effects of low-grade inflammation (elevated CRP) and Cpn seropositivity on endothelial function.
Economic recession in Finland in the 1960s and 1970s resulted in a migrant population of approx. 240 000 Finnish-born persons who now live permanently in Sweden. Finland and Sweden are neighbouring countries with very similar cultural backgrounds, living conditions and lifestyles. Nevertheless, CHD mortality rates have always been lower in Sweden [24] . Interestingly, in Finnish male migrants to Sweden, mortality rates decline and start to resemble those of the Swedish native population from 20 years after migration [25, 26] . This indicates that a change in environmental factor (or factors) is likely to be responsible for this observation. We have recently reported that, among migrant-discordant identical twin pairs, FMD of the brachial artery was significantly greater in the twin living permanently in Sweden, and this difference was not explained by differences in traditional risk factors [27] . Although there are no direct comparative studies, data from epidemiological studies carried out separately in the two countries suggest that chronic Cpn infection might occur less often in Sweden than in Finland [6, 28] . Therefore the purpose of the present study was to investigate whether there is a difference in the prevalence of Cpn seropositivity among men with similar genetic backgrounds but living either in Sweden or in Finland. Another objective was to study whether the combined effects of low-grade inflammation and Cpn seropositivity are associated with markers of subclinical atherosclerosis among these subjects.
METHODS

Subjects
A detailed description of the study population of 76 migration-discordant male twin pairs and the study protocol has been published previously [27] . In brief, male twin pairs with over 20 years' discordance for
The Biochemical Society residence in Sweden or Finland were identified from the Finnish Twin Cohort [29] and studied clinically in a 1-day protocol in Turku. Both members of a pair were always studied on the same day, with fasting blood sampling, an oral glucose tolerance test, a clinical examination and a dietary interview in the morning, and other procedures (described below) after lunch. In the present ultrasound analyses, we excluded one subject who had a CRP concentration of > 100 mg/l, reflecting acute infection. Among all other men, CRP concentrations ranged from 1 to 30 mg/l. Two subjects with inadequate image data from brachial artery ultrasound measurements were also excluded. Thus the final study population in the ultrasound studies consisted of 149 subjects. The studies were conducted according to the guidelines of the Helsinki Declaration, and the study protocol had been approved by the Joint Ethics Committee of Turku University and Turku University Central Hospital. All subjects gave their informed consent.
Ultrasound studies
All ultrasound studies were performed using an Acuson Sequoia 512 mainframe (Acuson, Mountain View, CA, U.S.A.) with a 13.0 MHz linear array transducer. Brachial artery scans were obtained at rest, during reactive hyperaemia (to study endothelium-dependent vasodilation, i.e. FMD) and after administration of 400 µg of sublingual glyceryl trinitrate spray (endothelium-independent vasodilation). All brachial ultrasound scans were recorded on super-VHS videotapes for later analysis. Vessel diameter was always measured independently by two observers who were 'blinded' to the subject's identity. Measurements were taken at end-diastole (incident with the R-wave on a continuously recorded ECG) from the anterior to the posterior intima-lumen interface (i-line) [27, 30] .
The carotid artery IMT was scanned in both common carotid arteries approx. 1 cm below the carotid bulbus from lateral and medial projections. A total of 16 measurements were obtained from both sides, and the average was taken as carotid IMT. The left common carotid artery diameter was measured 1 cm below the carotid bulb by using M-mode. The carotid artery diameter was measured at end-diastole and end-systole in two cardiac cycles and the means were used in calculation of carotid artery compliance (CAC) [27] .
Socioeconomic status
We initially divided the men into five socioeconomic classes: (1) unskilled manual workers (27.0 %), (2) skilled manual workers (44.1 %), (3) lower non-manual employees (5.3 %), (4) intermediate non-manual employees (10.5 %) and (5) higher non-manual employees (including farmers and self-employed) (13.2 %). Due to the small numbers of subjects, classes 3-5 (altogether 29.0 %) were united into one class.
Biochemical methods
Cpn-specific serum IgG and IgA antibodies were determined using a commercial micro-IF test kit (Labsystem, Helsinki, Finland). Elevated titre limits were 1:128 for IgG and 1:64 for IgA. Subjects were considered seropositive for Cpn if both IgG and IgA antibody levels were elevated. Subjects with IgM antibody titres of 1:8 were considered to have acute Cpn infection. CRP was assayed using an immunoturbidimetric method ('Tina-quant'; Boehringer Mannheim, Mannheim, Germany) in an automatic clinical chemistry analyser (Olympus AU 510). The sensitivity of the method was 1 mg/l, with an inter-assay coefficient of variation of 2.9 %.
Serum cholesterol and triacylglycerol concentrations were determined enzymically (Merck, Darmstadt, Germany) in an autoanalyser (AU 510; Olympus, Hamburg, Germany). For the separation of the verylow-density lipoprotein (VLDL) fraction, serum was centrifuged (18 h, 105 000 g) at a density of 1.006 g/ml. After removing VLDL, LDL was precipitated from the infranatant [high-density lipoprotein (HDL) + LDL] with dextran sulphate 500 000-magnesium chloride, according to the method of Kostner [31] .
Glucose metabolism was assessed in a standard 2 h glucose (75 g) tolerance test. Serum glucose was measured by the glucose dehydrogenase method (Merck). Fasting plasma insulin was measured using a microparticle enzyme immunoassay kit (Abbot Laboratories, Diagnostics Division, Dainabot, Tokyo, Japan). The method is highly specific to insulin (cross-reactivity with proinsulin = 0.005 %).
Definitions of CHD, diabetes and hypertension
Subjects were considered to have CHD if they had either a positive history of CHD or an ischaemic finding in stress echocardiography (for methods, see [27] ). Diabetes was defined as the use of antidiabetic medication and/or fasting serum glucose 7.0 mmol/l and/or 2 h glucose 11.1 mmol/l [32] . Hypertension was defined as the use of antihypertensive medication and/or an actual blood pressure of 160/95 mmHg.
Statistical methods
The results are expressed as means + − S.D., unless stated otherwise. For analyses of the relationship of antibody levels with country of residence, the twins represented fully discordant pairs, i.e. one twin of the pair was resident in Finland and the other always in Sweden.
Hence country differences could be tested using For the remaining analyses we considered the data as being from individuals with differing antibody levels. Statistical methods in general assume that subjects are unrelated observations, with independent error terms. Because the twins were sampled as twin pairs, and the error terms within pairs may be correlated, we used statistical techniques to take this into account, in order to derive correct standard errors and confidence intervals. Such statistical methods are used in studies with repeated measures or clustered data (e.g. family members sampled in households, pups in litters, etc.) [33] . Thus the equality of means between genotype groups was tested using regression models with generalized estimating equations [34] that specified that the individual observations were derived from twin pairs. To test the equality of distributions of dichotomous traits, a corresponding logistic regression model with generalized estimating equations was used. To test whether the association between elevated titres for Cpn and vascular parameters were independent of the effects of other co-variates, these were entered into a regression model with generalized estimating equations. All data analysis was carried out using SAS (version 6.12; SAS Institute, Cary, NC, U.S.A.), with generalized estimating equations regression analyses in SAS PROC GENMOD.
RESULTS
All subjects were included in Cpn antibody analyses. The prevalences of raised antibody titres for Cpn (IgA, IgG and IgA + IgG) are presented in Table 1 . The number of men considered seropositive for Cpn (both IgA and IgG) was higher among men living in Finland (16 compared with eight men; McNemar P = 0.046; with four twin pairs concordant for Cpn seropositivity). Adjusting for age and diabetes did not abolish the association between the prevalence of higher Cpn titres and country of residence (P = 0.043). Of the Cpn seropositive subjects,
Figure 1 Distribution of men according to their serum CRP concentration
Out of the study population, 67/149 men (= 45 % of subjects) had a CRP value of 1 mg/l.
29 % were monozygous and 71 % were dizygous twins. Among monozygous twins, 17 % were seropositive for Cpn, which was similar to the prevalence of Cpn seropositivity among dizygous twins (15 %). CRP levels were not different between monozygous and dizygous twins (P = 0.37). The distribution of CRP values is given in Figure 1 . There were 67 (45 %) men who had CRP levels of 1 mg/l. As elevated CRP levels (> 1 mg/l) together with Cpn seropositivity may reflect chronic low-grade inflammation due to Cpn, we compared men with this characteristic with all other men. There were 13 such subjects, nine in Finland and four in Sweden (McNemar P = 0.096, with two pairs concordant for the combination of Cpn seropositivity and CRP > 1 mg/l; Table 1 ).
The baseline characteristics of the study subjects stratified by Cpn seropositivity are presented in Table 2 . No subject had signs of acute Cpn infection, i.e. IgM antibody titres were 1:8 in all subjects. Subjects with Cpn seropositivity were older (P = 0.016) and had tendency towards a higher prevalence of diabetes (P = 0.062). The prevalence of Cpn seropositivity was not associated with place of birth (east or west Finland), socioeconomic factors or education. Among subjects resident in Sweden, age at migration tended to be higher in subjects that were Cpn seropositive.
FMD was significantly lower in subjects with Cpn seropositivity (P = 0.007) (Table 3) ; however, after adjusting for basal brachial artery diameter, which also differed between groups, the association between Cpn seropositivity and FMD disappeared (P = 0.43). There was no association between Cpn seropositivity and other markers of subclinical atherosclerosis, i.e. IMT and CAC. Men with Cpn seropositivity in combination with elevated CRP levels had a higher incidence of diabetes (P = 0.03) and tended to be older (P = 0.06) ( Table 4) . Brachial artery FMD was significantly impaired in these men (P = 0.0001) ( Table 5 ). After adjusting separately for basal brachial artery diameter, age, diabetes, smoking, total cholesterol or systolic blood pressure, the difference in FMD between men with and without the combination of Cpn seropositivity and elevated CRP levels persisted.
Furthermore, after adjusting for all aforementioned risk factors simultaneously (age, diabetes, systolic blood pressure, total cholesterol and smoking status), the difference between groups persisted (P = 0.0046). In bivariate regression analyses that included baseline diameter and each risk factor separately, the difference in FMD between men with and without the combination of Cpn seropositivity and elevated CRP levels was diminished, but was still significant or of borderline significance (Table 5) . IMT was significantly higher in men with the combination of Cpn seropositivity and elevated CRP levels than in those without this combination, but this difference was decreased to below statistical significance after adjusting for age. 
DISCUSSION
We found that the prevalence of Cpn seropositivity was significantly higher among men living in Finland compared with their co-twins living in Sweden. As our study subjects were twins (30 % of the pairs were monozygous) and also had a shared environment during childhood and adolescence, our results suggest that living as an adult in Sweden is associated with a lower risk of chronic Cpn infection. We have no definite explanation as to why the men living in Sweden had a lower Cpn seropositivity rate. The Finnish population is more scattered than that in Sweden. It may be argued that in densely populated areas Cpn epidemics occur more frequently, and therefore are milder and affect only the upper respiratory tract. In sparsely populated areas, however, epidemics of Cpn probably occur seldom, and Cpn infections thus may be more invasive and also affect the lower respiratory tract, leading to persistent anti-Cpn antibody production. The prevalence of seropositivity for Cpn was not associated with place of birth, socioeconomic factors, education or smoking. Among migrants, those who were Cpn seronegative tended to be younger at the time of migration than those who were seropositive. This supports the idea that longer residence in Sweden may protect against chronic Cpn infection. There are no previous studies on direct comparisons of Cpn seropositivity between Finland and Sweden. However, our finding is in accordance with the two previously published epidemiological studies. First, Gnarpe and co-workers [28] used samples from blood banks to estimate the prevalence of Cpn seropositivity in Sweden. In non-epidemic years, the prevalence of elevated levels of IgA (> 1:64) and IgG (> 1:512) in men varied between 5 % and 12 % [28] . Secondly, in Finland, Saikku and co-workers [6] reported in the Helsinki Heart Study prevalences of elevated Cpn titres of IgA (> 1:64) and IgG (> 1:128) of 22 % and 14 % respectively. We used the same cut-off points, and our results are similar to the previously reported values in Finnish middle-aged men.
The present study showed that Cpn seropositive men with concomitantly mildly elevated CRP levels had significantly attenuated brachial artery endothelial function. Previously, Sharma and co-workers [21] observed a trend towards attenuated endothelial function in subjects with either elevated Cpn IgA or elevated CRP levels. We showed that the combination of Cpn seropositivity and elevated CRP was related to attenuated FMD more clearly than was Cpn seropositivity alone. Recently, a favourable effect on endothelial function in patients with documented coronary artery disease and evidence of Cpn infection was shown after 5 weeks of azithromycin treatment [35] .
Cpn seropositivity was determined by a microimmunofluoresence method, which according to current guidelines is the only recommended serological method [36] . The use of a single Cpn antibody determination as a marker for chronic infection is discouraged [36] . It is still not fully established whether elevated antibody titres of IgG and IgA represent chronic active or acute infection or re-infection. None of our men had elevated IgM levels, a strong indicator of recent infection. Serial determinations of Cpn IgG and IgA over a time period of months to years are recommended in order to judge definitively whether elevated levels of these antibody titres are a marker of chronic Cpn infection [36] . Because we obtained only single Cpn IgA and IgG antibody measurements, we hypothesized that the combination of elevated Cpn antibodies (both IgA and IgG) levels and elevated CRP would be a marker of chronic low-grade inflammation due to Cpn infection. A corresponding combination was used previously in the Helsinki Heart Study, where the risk of coronary events was markedly elevated in the presence of elevated CRP levels and seropositivity to Cpn. The odds ratio was 6.7 in Cpn seropositive subjects with elevated CRP levels, compared with only 1.3 when Cpn seropositivity was not accompanied by CRP elevation [37] . Although the combination of Cpn seropositivity and elevated CRP levels in the Helsinki Heart Study and in our present study was shown to be disadvantageous, we have no direct evidence that this combination necessarily reflects chronic low-grade inflammation specifically due to chronic Cpn infection.
The method used for measuring CRP levels in the present study was of intermediate sensitivity, and not a supersensitive method. Our method cannot discriminate values below 1 mg/l. However, the CRP distribution found using our method was similar to distributions reported in studies using supersensitive methods [38, 39] . Although supersensitive CRP methods are highly recommended when evaluating CHD risk, we think that, when using CRP level as a dichotomous variable, as in our study, an assay of intermediate sensitivity probably gives data comparable with those obtained with a more sensitive method.
The difference in mean IMT between men with and without either seropositivity to Cpn or the combination of Cpn seropositivity and elevated CRP levels was marked, although statistically non-significant (Tables 3  and 5 ). The number of men with the combination of Cpn seropositivity and elevated CRP levels was only 12. A higher number of such subjects may possibly have uncovered a significant difference in IMT between men with and without this combination. Several previous studies [15, 18, 40, 41] , but not all [16, 42] , have shown an association between increased carotid IMT and chronic Cpn infection. Differences in the definition of Cpn seropositivity, the techniques used to assess Cpn antibodies and study populations (gender, ethnicity, etc.) may at least partly explain the discrepant findings of the previous studies.
The mechanisms by which Cpn may trigger atherosclerosis are unknown. In addition to initiating atherosclerosis, Cpn may act as a promoter of plaque growth or a precipitator of plaque rupture. In general, inflammation in the arterial wall causes endothelial damage and dysfunction, and precedes intimal thickening [1] . Evidence for a role for Cpn in initiating atheroclerosis comes from experimental animal studies. Intimal thickening and fatty streaks were observed in rabbits infected with Cpn [43, 44] . Autopsy data from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study showed that Cpn can be found in coronary lesions in young adults with atherosclerotic lesions, i.e. fatty streaks, fatty plaques or fibrous plaques, but not in age-and sex-matched controls without evidence of atherosclerosis [45] . Pathological findings from more advanced atherosclerotic plaques give further support to a role for Cpn in the atherosclerotic process [17, 46, 47] . Cpn DNA, protein or elementary bodies have been found in nearly half of atheromatous lesions [2, 48] . The consequences of pharmacological interventions to prevent or treat the sequelae of Cpn in arteries have been studied in animals and in humans. Muhlestein and coworkers [49] showed that rabbits infected intranasally with Cpn had accelerated intimal thickening, which could be prevented by simultaneous azithromycin treatment. Two relatively small studies have shown a reduction in cardiovascular events following antibiotic treatment [50, 51] ; however, in a larger trial such a favourable effect on clinical events in patients with coronary artery disease could not be seen [52] . A recent study showed a reduction in the risk of ischaemic cardiovascular events in patients presenting with acute non-Q-wave infarction or unstable angina who were treated with clarithromycin [53] . Most recently, roxithromycin treatment for 1 month after stroke in patients with chronic Cpn infection reduced the rate of carotid IMT progression during the subsequent 2 years [54] . On the other hand, there are also studies showing no association between seropositivity for Cpn and CHD [10, 11] , and preliminary data from new intervention trials were negative, thus leaving the definitive role of Cpn in atherogenesis unresolved [55] .
Chronic Cpn infection has been linked to higher levels of triacylglycerols and total cholesterol, and lower HDL cholesterol concentrations [56] . We found no significant differences in lipid levels in our present study, although the total cholesterol level tended to be somewhat higher in subjects with the combination of Cpn seropositivity and elevated CRP. The prevalence of elevated levels of antibodies for Cpn is related to age [57] . This was also true in our study, where subjects with Cpn seropositivity alone or accompanied by elevated CRP levels were somewhat older than the other men. Our finding that men with chronic Cpn infection accompanied by chronic inflammation had attenuated endothelial function was not abolished when adjusting for age alone, but the difference between men with and without Cpn seropositivity accompanied by elevated CRP became of borderline significance when adjusting FMD simultaneously for age and brachial artery diameter. This may have a major effect when interpreting our data on the association between endothelial function and the combination of Cpn seropositivity and elevated CRP levels. Adjusting for other CHD risk factors (diabetes, total cholesterol, smoking or systolic blood pressure) had no significant effect on our finding.
A role for smoking in predisposing to chronic Cpn infection has been suggested [58, 59] . Smoking was strongly associated with Cpn seropositivity in a sample of 111 same-gender smoking-discordant twin pairs from the Finnish Twin Cohort [59] sampled on the basis of smoking history. A significantly higher proportion of men with a history of smoking had elevated levels of serum IgA antibodies, whereas in women a significant difference between smoking-discordant co-twins was found in the proportion of IgG seropositive subjects. The number of smoking-discordant twins in the present study was too small (only 14 smoking-discordant pairs, of which only five men were Cpn seropositive) to allow pairwise analysis of the effect of smoking on the predisposition to chronic Cpn infection. However, when combining all men, there were no marked differences in smoking habits between Cpn seropositive and seronegative men.
Due to the unique setting of our study, the number of subjects was limited. However, even in such a small study sample, we were able to find a difference in endothelial function between men with and without the combination of Cpn seropositivity and elevated CRP. We also observed a difference in the prevalence of Cpn seropositivity between Finland and Sweden. As our study was cross-sectional, we only obtained single Cpn antibody determinations. Serial determinations might have revealed an even stronger association between the combination of Cpn seropositivity and elevated CRP and markers of subclinical atherosclerosis.
We conclude that the incidence of Cpn seropositivity was lower in a country with lower CHD mortality when considering a population of male twin pairs discordant for permanent country of residence in adulthood. Subjects with raised titres against Cpn in addition to mildly elevated CRP levels tended to have attenuated endothelial function. This may be one possible mechanism whereby chronic Cpn infection could lead to atherosclerosis.
